Carbon Nanoparticle Iron Suspension for Injection
YR-2025-01-CNSI-Fe
Phase 2 small_molecule active
Quick answer
Carbon Nanoparticle Iron Suspension for Injection for HNSCC is a Phase 2 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- HNSCC
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active